Cyndi Clark

David Merryman, associate professor of biomedical engineering, found that a drug developed for rheumatoid arthritis stops a common binding protein from calcifying heart valves. (Vanderbilt University)

Drug developed for arthritis could be first to stop heart valve calcification

The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis.